Evidence map›Paper›PMID 23844252›Full record

ArticlePloS one2013

Norepinephrine inhibits macrophage migration by decreasing CCR2 expression.

Fangming Xiu, Mile Stanojcic, Marc G Jeschke

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. αPharmacological research · 2023
    Article
  6. Article
  7. Review
  8. 17Biomedicines · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Renal sympathetic nerve activation via αKidney research and clinical practice · 2019
    Article
  13. Article
  14. Review
  15. Immune therapy in sepsis: Are we ready to try again?Journal of the Intensive Care Society · 2018
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Fangming XiuRoss Tilley Burn Centre, Sunnybrook Health Science Centre, Sunnybrook Research Institute, Division of Plastic Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
Mile Stanojcic
Marc G Jeschke
Sunnybrook Health Science Centre · CA

Funding

Hepatic ER stress contributes to morbidity and mortality after burn injury.R01GM087285 · NIGMS · SUNNYBROOK & WOMEN'S COLL HLTH SCIS CTR · PI BOEHNING, DARREN F, JESCHKE, MARC GERHARD · 2010 to 2018
$1.9M
CIHR 123336NIGMS NIH HHS NIH RO1 GM087285-01NIGMS NIH HHS R01 GM087285
6 · The paper itself

Abstract

Increased incidences of infectious and septic complications during post-burn courses represent the main contributor to burn injury mortality. Sustained increases in catecholamine levels, especially norepinephrine (NE), contribute to immune disturbances in severely burned patients. The precise mechanisms underlying NE-mediated immunoregulation are not fully understood. Here we hypothesize that persistently elevated NE levels are associated with immunodysfunctions. We examined the effects of NE on the phenotype and functions of bone marrow-derived macrophages (BMMs). Whole mouse bone marrow cells were treated in vitro with 40 ng/mL of M-CSF and with 1 x 10(-6) M or 1 x 10(-8) M of NE or without NE for 7 days; cells were collected and stained with antibodies for CD11b, F4/80, MHC II and the inflammatory CC chemokine receptor 2 (CCR2). We found 1 x 10(-6) M of NE inhibited MHC II and CCR2 expression on CD11b(+)/F4/80(+) BMM cells. It also inhibited BMM proliferation by inhibiting CSF-1R expression. On the contrary, 1 x 10(-8) M of NE slightly increased both MHC II and CCR2 expression on CD11b(+)/F4/80(+) BMM cells but inhibited CD11b(+)/F4/80(+) BMM proliferation. MCP-1 based migration assay showed that the migration of 1 x 10(-6) M of NE-treated BMM toward MCP-1 was significantly decreased compared to BMM without NE treatment. Both 1 x 10(-8) M and 1 x 10(-6) M of NE enhanced TNF-α production and phagocytosis of FITC-Dextran. Intracellular staining of transcriptional factor MafB showed that 1 x 10(-6) M of NE treatment enhanced its expression, whereas 1 x 10(-8) M of NE decreased expression. Stimulation with LPS in the last 24-hours of BMM culture further decreased CCR2 and MHC II expression of these BMM, suggesting the synergistic effect of LPS and NE on macrophage. Our results demonstrate that NE regulates macrophage differentiation, proliferation and function, and may play a critical role in the dysfunctional immune response post-burn.

Indexed as

AnimalsAntigens, DifferentiationBone Marrow CellsCD11b AntigenCell DifferentiationCell MovementCell ProliferationCells, CulturedDose-Response Relationship, DrugDrug SynergismFemaleFlow CytometryHistocompatibility Antigens Class IILipopolysaccharidesMacrophagesMafB Transcription FactorAntigens, DifferentiationCcr2 protein, mouseCD11b AntigenHistocompatibility Antigens Class IILipopolysaccharidesMafb protein, mouseMafB Transcription Factormonocyte-macrophage differentiation antigenNorepinephrineReceptor, Macrophage Colony-Stimulating FactorReceptors, CCR2Tumor Necrosis Factor-alpha

Identifiers

PMID23844252
PMCPMC3699643
OpenAlexW2090171084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.